Ulli Simone Bankstahl

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –

Thorsten Oliver Goetze, Wolf O. Bechstein, Ulli Simone Bankstahl et al. · BMC Cancer · 2020 · 81 citations · Full text

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

Thorsten Oliver Götze, Pompiliu Piso, Sylvie Lorenzen et al. · BMC Cancer · 2021 · 48 citations · Full text

Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.

Salah‐Eddin Al‐Batran, Alexander Reichart, Ulli Simone Bankstahl et al. · Journal of Clinical Oncology · 2021 · 36 citations

Surgical Oncology, Cancer Management, Pathology +19

Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.

Salah‐Eddin Al‐Batran, Sylvie Lorenzen, Jorge Riera et al. · Journal of Clinical Oncology · 2024 · 35 citations · Full text

Surgical Oncology, Esophageal Cancer, Lba4001 Background +17

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion—A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Harald Schmalenberg et al. · Journal of Clinical Oncology · 2020 · 30 citations

Surgical Oncology, Esophageal Cancer, Gastroenterology +17